Sign In
Buy CUE
$26.91
-1.71 (-5.97%)
At Close: Jun 03, 2026
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
03:07pm, Friday, 24'th Apr 2020
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
3 Monster Growth Stocks Gearing up for Gains
02:50pm, Friday, 24'th Apr 2020
Just when it looked like time to throw in the towel, the market pulled through and delivered a win. Stabilizing crude oil prices, a few better-than-expected earnings reports as well as the possibility
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Chemb
5 Stocks With Recent Price Strength to Tap Market Rally
11:50am, Friday, 24'th Apr 2020
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Stocks That Hit 52-Week Highs On Thursday
02:41pm, Thursday, 23'rd Apr 2020
During Thursday's morning trading, these companies set new 52-week highs.Noteworthy Points: * Johnson & Johnson (NYSE: JNJ) was the largest company by market cap to set a new 52-week high. * The sm
Stocks Recover About 2% After Oil Stabilizes
01:15pm, Thursday, 23'rd Apr 2020
Stocks Recover About 2% After Oil Stabilizes
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
11:25am, Thursday, 23'rd Apr 2020
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
11:25am, Thursday, 23'rd Apr 2020
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
Cue Biopharma price target raised to $25 from $21 at Stifel CUE
11:58am, Tuesday, 21'st Apr 2020
Cue Biopharma price target raised to $25 from $21 at Stifel Stifel CUE
Cue Biopharma, Merck enter into clinical trial collaboration agreement CUE;MRK
12:37pm, Monday, 20'th Apr 2020
Cue Biopharma, Merck enter into clinical trial collaboration agreement CUE MRK
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced t
Cronos Financials 'Restatement', And Other News: The Good, Bad And Ugly Of Biopharma
04:24pm, Friday, 20'th Mar 2020
Cronos said it will need to restate parts of its financial statements. Biohaven's migraine drug gets fast tracked. Cue biopharma's earnings.
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
08:05pm, Tuesday, 17'th Mar 2020
Extended cash runway with $33.3 million from at-the-market equity offerings in Q4’19Focused and effective execution of clinical development of CUE-101 as a Phase 1 monotherapy.
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
01:55pm, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc
